New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

Bookmark and Share
Published: 27 Sep 2014
Views: 3901
Prof David Currow - Flinders University, Adelaide, Australia

At a press conference at ESMO 2014, Prof Currow presents the data from a phase III trial which showed that anamorelin improved appetite and body mass in patients with advanced lung cancer who were suffering with cancer anorexia and cachexia.

Read the news story and watch the interview for more.